Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
CJJD - China Jo-Jo Drugstores Inc - Stock Price Chart
TickerCJJD [NASD]
CompanyChina Jo-Jo Drugstores Inc
CountryChina
IndustryPharmaceutical Retailers
Market Cap7.80MEPS (ttm)-39.61
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.97%
P/S0.05EPS next 5Y30.00%
P/B0.23EPS Q/Q96.35%
Dividend-Sales Q/Q17.70%
Insider Own31.47%Inst Own0.79%
Insider Trans0.00%Inst Trans-3.63%
Short Float0.88%Earnings-
Analyst Recom-Target Price-
Avg Volume71.19K52W Range1.95 - 17.72
May-10-24 09:20AM China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering (PR Newswire) -8.93%
Apr-29-24 01:07PM China Jo-Jo Drugstores Shares Slump After $1.5 Million Direct Offering Announcement (MT Newswires) -15.31%
09:00AM China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering (PR Newswire)
Mar-19-24 04:05PM China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Feb-27-24 04:05PM China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split (PR Newswire)
Dec-14-23 08:30AM China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement (PR Newswire) +9.27%
Nov-08-23 08:30AM China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary (PR Newswire)
Sep-26-23 09:00AM China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering (PR Newswire) -8.56%
Jun-16-23 04:29PM China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
06:23AM China Jo-Jo Drugstores Full Year 2023 Earnings: US$2.07 loss per share (vs US$0.92 loss in FY 2022) (Simply Wall St.)
ACET - Adicet Bio Inc - Stock Price Chart
TickerACET [NASD, RUT]
CompanyAdicet Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap129.01MEPS (ttm)-2.95
P/E-EPS this Y48.60%
Forward P/E-EPS next Y1.58%
PEG-EPS past 5Y19.75%
P/S-EPS next 5Y29.10%
P/B0.50EPS Q/Q50.72%
Dividend-Sales Q/Q-
Insider Own17.50%Inst Own75.38%
Insider Trans76.88%Inst Trans7.02%
Short Float11.32%EarningsMay 14/a
Analyst Recom1.50Target Price9.20
Avg Volume1.43M52W Range1.10 - 7.06
May-14-24 09:54PM ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024 (InvestorPlace) -7.64%
04:01PM Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates (Business Wire)
10:00AM Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress (Business Wire)
May-07-24 07:00AM Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference (Business Wire)
Apr-30-24 05:10PM Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.29%
Apr-22-24 04:30PM Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting (Business Wire)
Apr-08-24 07:00AM Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Apr-04-24 08:38AM Why Adicet Bio (ACET) Stock Might be a Great Pick (Zacks)
Apr-01-24 09:40AM Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-28-24 05:19PM Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
HUYA - HUYA Inc ADR - Stock Price Chart
TickerHUYA [NYSE]
CompanyHUYA Inc ADR
CountryChina
IndustryEntertainment
Market Cap473.91MEPS (ttm)-0.10
P/E-EPS this Y229.94%
Forward P/E25.47EPS next Y59.11%
PEG-EPS past 5Y44.57%
P/S0.52EPS next 5Y-6.68%
P/B1.06EPS Q/Q57.14%
Dividend-Sales Q/Q-26.56%
Insider Own0.20%Inst Own57.42%
Insider Trans0.00%Inst Trans-0.96%
Short Float2.23%EarningsMay 13/b
Analyst Recom2.00Target Price5.28
Avg Volume1.68M52W Range1.84 - 5.59
May-14-24 08:20AM HUYA Inc. (NYSE:HUYA) Q1 2024 Earnings Call Transcript (Insider Monkey) +16.70%
05:37AM Analyst Report: HUYA Inc. (Morningstar Research)
03:43AM Q1 2024 HUYA Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-24 01:30PM HUYA (HUYA) Q1 2024 Earnings Call Transcript (Motley Fool) +7.01%
10:53AM HUYA Stock Earnings: HUYA Beats Revenue for Q1 2024 (InvestorPlace)
06:20AM HUYA Q1 Net Income Rises (RTT News)
06:00AM HUYA Inc. Reports First Quarter 2024 Unaudited Financial Results (PR Newswire)
May-03-24 07:00AM 3 Little-Known Stocks That Could Make You Rich by 2029 (InvestorPlace)
Apr-26-24 06:30AM HUYA Inc. Files 2023 Annual Report on Form 20-F (PR Newswire)
Apr-23-24 05:50PM HUYA Inc. Sponsored ADR (HUYA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
IXHL - Incannex Healthcare Inc - Stock Price Chart
TickerIXHL [NASD]
CompanyIncannex Healthcare Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap44.12MEPS (ttm)-0.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.94%
P/S-EPS next 5Y-
P/B2.34EPS Q/Q-294.91%
Dividend-Sales Q/Q-
Insider Own27.69%Inst Own1.18%
Insider Trans0.00%Inst Trans-
Short Float0.48%Earnings-
Analyst Recom-Target Price-
Avg Volume320.38K52W Range1.96 - 12.68
May-07-24 07:30AM Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder (GlobeNewswire)
May-01-24 02:33PM Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD) (Newsfile) -7.61%
Apr-16-24 08:00AM Incannex Healthcare Inc. Quarterly Update, Q1 2024 (GlobeNewswire) -8.30%
Mar-24-24 07:55AM 11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-28-24 07:30AM Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder (GlobeNewswire) +48.58%
Feb-16-24 07:30AM Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation (GlobeNewswire) +5.68%
Feb-01-24 07:30AM Clarion Clinics Open for Psychedelic-Assisted Treatments (GlobeNewswire) -6.40%
Jan-24-24 04:05PM Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis (GlobeNewswire)
Jan-18-24 08:22AM Incannex Completes Dosing and Therapy in Phase 2 PsiGAD Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences (GlobeNewswire)
Jan-17-24 07:30AM Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea (GlobeNewswire)
DFH - Dream Finders Homes Inc - Stock Price Chart
TickerDFH [NYSE, RUT]
CompanyDream Finders Homes Inc
CountryUSA
IndustryResidential Construction
Market Cap2.69BEPS (ttm)2.81
P/E10.20EPS this Y14.85%
Forward P/E8.26EPS next Y8.33%
PEG-EPS past 5Y70.07%
P/S0.71EPS next 5Y-5.40%
P/B2.77EPS Q/Q22.34%
Dividend-Sales Q/Q7.59%
Insider Own71.57%Inst Own25.43%
Insider Trans-1.36%Inst Trans2.28%
Short Float13.31%EarningsMay 02/b
Analyst Recom3.00Target Price32.00
Avg Volume475.40K52W Range16.30 - 44.38
May-08-24 09:00AM Investors Heavily Search Dream Finders Homes, Inc. (DFH): Here is What You Need to Know (Zacks)
May-06-24 09:40AM Are Investors Undervaluing Dream Finders Homes (DFH) Right Now? (Zacks)
May-02-24 01:54PM DFH Stock Earnings: Dream Finders Homes Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -9.48%
08:35AM Dream Finders Homes Inc. (DFH) Q1 Earnings and Revenues Miss Estimates (Zacks)
07:00AM Dream Finders Announces First Quarter 2024 Results (Business Wire)
Apr-30-24 12:30PM What's in Store for Dream Finders Homes (DFH) in Q1 Earnings? (Zacks)
Apr-28-24 06:43PM 27 Cheapest Housing Markets in the US (Insider Monkey)
Apr-25-24 05:45PM Why Dream Finders Homes Inc. (DFH) Dipped More Than Broader Market Today (Zacks)
10:02AM Dream Finders Homes Inc. (DFH) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
Apr-24-24 09:00AM Here is What to Know Beyond Why Dream Finders Homes, Inc. (DFH) is a Trending Stock (Zacks)
ICAD - Icad Inc - Stock Price Chart
TickerICAD [NASD]
CompanyIcad Inc
CountryUSA
IndustryMedical Devices
Market Cap46.67MEPS (ttm)-0.12
P/E-EPS this Y13.00%
Forward P/E-EPS next Y22.73%
PEG-EPS past 5Y11.68%
P/S2.38EPS next 5Y15.00%
P/B1.44EPS Q/Q68.98%
Dividend-Sales Q/Q-14.26%
Insider Own5.84%Inst Own24.42%
Insider Trans0.00%Inst Trans-4.85%
Short Float1.06%EarningsMay 15/b
Analyst Recom1.00Target Price4.83
Avg Volume195.55K52W Range1.05 - 3.97
May-16-24 03:01AM icad Inc (ICAD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth and Operational ... (GuruFocus.com) +8.59%
May-15-24 11:52AM ICAD Stock Earnings: icad Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00AM iCAD Reports Financial Results for First Quarter Ended March 31, 2024 (GlobeNewswire)
07:57AM Icad: Q1 Earnings Snapshot (Associated Press Finance)
May-08-24 09:49AM UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 (GlobeNewswire)
May-02-24 08:00AM iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 (GlobeNewswire)
Apr-11-24 08:00AM iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium (GlobeNewswire)
Apr-09-24 08:00AM iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation (GlobeNewswire) +10.43%
Apr-08-24 04:29PM iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting (GlobeNewswire)
Apr-03-24 08:00AM iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) (GlobeNewswire) +18.75%
ANRO - Alto Neuroscience Inc. - Stock Price Chart
TickerANRO [NYSE]
CompanyAlto Neuroscience Inc.
CountryUSA
IndustryBiotechnology
Market Cap344.60MEPS (ttm)-
P/E-EPS this Y71.38%
Forward P/E-EPS next Y-11.67%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.78EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own17.15%Inst Own57.66%
Insider Trans15.77%Inst Trans-
Short Float11.18%EarningsMay 14/a
Analyst Recom1.17Target Price35.55
Avg Volume176.22K52W Range12.78 - 24.00
May-14-24 10:54PM ANRO Stock Earnings: Alto Neuroscience Misses EPS for Q1 2024 (InvestorPlace)
04:03PM Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights (Business Wire)
May-09-24 08:05AM Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences (Business Wire) +5.19%
Apr-23-24 08:05AM Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia (Business Wire)
Apr-10-24 03:30PM Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Apr-09-24 09:37AM Alto Neuroscience (ANRO): Strong Industry, Solid Earnings Estimate Revisions (Zacks)
Apr-03-24 08:05AM Alto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive Disorder (Business Wire)
Mar-21-24 04:05PM Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights (Business Wire)
Mar-11-24 08:05AM Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors (Business Wire) +5.74%
Mar-07-24 08:00AM Alto Neuroscience to Participate in Upcoming Investor Conferences (Business Wire)
IPX - IperionX Ltd ADR - Stock Price Chart
TickerIPX [NASD]
CompanyIperionX Ltd ADR
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap317.66MEPS (ttm)-0.95
P/E-EPS this Y-332.03%
Forward P/E-EPS next Y26.85%
PEG-EPS past 5Y2.26%
P/S-EPS next 5Y-
P/B10.32EPS Q/Q15.90%
Dividend-Sales Q/Q-
Insider Own-Inst Own8.64%
Insider Trans-Inst Trans-
Short Float0.18%EarningsMar 15/b
Analyst Recom1.00Target Price24.06
Avg Volume30.80K52W Range5.11 - 18.57
May-01-24 08:30AM IperionX and Vegas Fastener to Co-Produce Titanium Fasteners for U.S. Army (Business Wire)
Apr-26-24 08:30AM IperionX Titanium HAMR Furnace Installation Complete (Business Wire)
Apr-15-24 08:30AM IperionX Partners With United Stars for U.S. Sourced Titanium Manufacturing (Business Wire) -5.10%
Feb-14-24 08:30AM IperionX Drives Towards Commercial Scale Titanium Metal Production (Business Wire) +10.47%
Jan-16-24 08:30AM IperionX Letter to Shareholders (Business Wire)
Nov-29-23 09:00AM IperionX 2023 Sustainability Report (Business Wire)
Nov-08-23 08:30AM IperionX Completes US$16.7M Placement to Re-shore U.S. Titanium Production (Business Wire)
Nov-01-23 08:30AM IperionX Receives US$12.7M U.S. Department of Defense Grant for Domestic Titanium Production (Business Wire) +18.69%
Oct-19-23 08:30AM IperionX Receives US$11.5 Million LOI From EXIM Bank for U.S. Titanium Production (Business Wire) -13.77%
Oct-09-23 08:30AM IperionX Company Presentation (Business Wire)
KAVL - Kaival Brands Innovations Group Inc - Stock Price Chart
TickerKAVL [NASD]
CompanyKaival Brands Innovations Group Inc
CountryUSA
IndustryTobacco
Market Cap9.01MEPS (ttm)-3.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-252.44%
P/S0.65EPS next 5Y-
P/B0.77EPS Q/Q31.77%
Dividend-Sales Q/Q27.14%
Insider Own70.51%Inst Own0.14%
Insider Trans0.00%Inst Trans-82.26%
Short Float5.92%EarningsMar 27/b
Analyst Recom1.00Target Price5.00
Avg Volume2.51M52W Range1.11 - 20.27
Mar-27-24 08:30AM Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update (GlobeNewswire) -13.54%
Mar-21-24 07:49AM Why Is Kaival Brands Innovations (KAVL) Stock Up 77% Today? (InvestorPlace) +118.80%
Feb-14-24 04:15PM Kaival Brands Provides Business Update in Letter to Shareholders (GlobeNewswire)
Jan-29-24 08:15AM Kaival Brands Partner Bidi Vapor to Contest FDA Denial of 'Classic' Tobacco-Flavored ENDS (GlobeNewswire) +6.81%
Jan-23-24 08:15AM Kaival Brands Innovations Group Announces Reverse Stock Split (GlobeNewswire) -6.18%
Dec-28-23 08:30AM Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President (GlobeNewswire) +9.10%
Dec-07-23 08:30AM Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel (GlobeNewswire) +16.94%
Nov-29-23 11:25AM Kaival Brands, Exclusive Distributor of Bidi Vapor Products to the E-Cigarette and Vape Industry, Featured in InvestmentPitch Media Video (Newsfile) +22.67%
Nov-13-23 08:15AM Kaival Brands Expands Senior Management Team with the Appointment of Barry Hopkins as Executive Chairman (GlobeNewswire)
Nov-07-23 08:15AM Kaival Brands Leads the Way in Compliance as FDA Ramps Up Enforcement of Illicit Vape Products (GlobeNewswire)
CELU - Celularity Inc - Stock Price Chart
TickerCELU [NASD]
CompanyCelularity Inc
CountryUSA
IndustryBiotechnology
Market Cap66.43MEPS (ttm)-5.50
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S4.49EPS next 5Y-
P/B1.95EPS Q/Q-15726.96%
Dividend-Sales Q/Q-8.44%
Insider Own51.56%Inst Own14.28%
Insider Trans190.66%Inst Trans377.53%
Short Float5.64%Earnings-
Analyst Recom1.00Target Price25.00
Avg Volume73.78K52W Range1.59 - 8.90
May-14-24 09:15AM Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy (GlobeNewswire) +25.95%
Apr-22-24 08:00AM Celularity Inc. to Host Investor and Analyst Research & Development Day (GlobeNewswire)
Apr-19-24 05:30PM Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing (GlobeNewswire) -5.61%
Apr-18-24 04:30PM Celularity Abstract Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials Accepted at ORS Tendon Conference 2024 (GlobeNewswire)
Apr-15-24 08:00AM Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products (GlobeNewswire)
Apr-08-24 09:00AM Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells (GlobeNewswire)
Mar-26-24 09:00AM Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L (GlobeNewswire)
Mar-20-24 09:15AM Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy (GlobeNewswire)
Mar-14-24 09:15AM Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit (GlobeNewswire)
Mar-12-24 09:20AM Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress (GlobeNewswire) -15.30%
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.